Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Selectis Health (GBCS) Return on Equity (2017 - 2025)

Selectis Health's Return on Equity history spans 13 years, with the latest figure at 0.43% for Q3 2025.

  • For Q3 2025, Return on Equity fell 155.0% year-over-year to 0.43%; the TTM value through Sep 2025 reached 0.43%, down 155.0%, while the annual FY2024 figure was 1.14%, 993.0% down from the prior year.
  • Return on Equity for Q3 2025 was 0.43% at Selectis Health, down from 0.6% in the prior quarter.
  • Across five years, Return on Equity topped out at 9.74% in Q4 2023 and bottomed at 5.47% in Q3 2023.
  • The 5-year median for Return on Equity is 0.13% (2022), against an average of 0.32%.
  • The largest annual shift saw Return on Equity soared 1096bps in 2023 before it plummeted -881bps in 2024.
  • A 5-year view of Return on Equity shows it stood at 0.99% in 2021, then decreased by -23bps to 1.22% in 2022, then skyrocketed by 899bps to 9.74% in 2023, then tumbled by -90bps to 0.93% in 2024, then plummeted by -54bps to 0.43% in 2025.
  • Per Business Quant, the three most recent readings for GBCS's Return on Equity are 0.43% (Q3 2025), 0.6% (Q2 2025), and 0.77% (Q1 2025).